HKU Scholars Hub: Browsing DSpace

Browsing by Author Nguyen, TT

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 5 to 11 of 11 < previous

	Title	Author(s)	Issue Date	Views
	Reduced changes in bone mineral density in Chronic HBV (CHB) Patients receiving Tenofovir Alafenamide (TAF) compared with Tenofovir Disoproxil Fumarate (TDF) Proceeding/Conference:The Liver Meeting® 2016	Seto, WKW Asahina, Y Peng, CY Stanciu, C Abdurakhmanov, D Flaherty, J Kim, K Gaggar, A Subramanian, M Tabak, F Nguyen, TT Chan, HLY	2016	52
	Reduced changes in bone mineral density in chronic hepatitis B patients receiving TAF compared with TDF Proceeding/Conference:Conference of the Asian Pacific Association for the Study of the Liver, APASL 2017	Seto, WKW Asahina, Y Peng, CY Stanciu, C Abdurakhmanov, D Flaherty, J Kim, L Gaggar, A Subramanian, M Tabak, F Nguyen, TT Chan, HLY	2017	38
	RETRACTION: Improved Bone Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate Over 2 Years in Patients With Chronic HBV Infection Journal:Clinical Gastroenterology and Hepatology	Seto, WKW Asahina, Y Brown, TT Peng, CY Stanciu, C Abdurakhmanov, D Tabak, F Nguyen, TT Chuang, WL Inokuma, T Ikeda, F Santantonio, TA Habersetzer, F Ramji, A Lau, AH Suri, V Flaherty, JF Wang, H Gaggar, A Subramanian, GM Mukewar, S Brunetto, MR Fung, S Chan, HL	2018	50
	Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection Journal:Journal of Hepatology	Sulkowski, MS Agarwal, K Ma, XL Nguyen, TT Schiff, ER Hann, H-W L Dieterich, DT Nahass, RG Park, JS Chan, S Han, S-H B Gane, EJ Bennett, M Alves, K Evanchik, M Yan, R Huang, Q Lopatin, U Colonno, R Ma, J Knox, SJ Stamm, LM Bonacini, M Jacobson, IM Ayoub, WS Weilert, F Ravendhran, N Ramj, A Kwo, PY Elkhashab, M Hassanein, T Bae, HS Lalezari, JP Fung, SK Yuen, RMF	2022
	Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection Journal:Journal of Hepatology	Yuen, RMF Agarwal, K Ma, XL Nguyen, TT Schiff, ER Hann, H-WL Dieterich, DT Nahass, RT Park, JS Chan, S Han, S-H B Gane, EJ Bennett, M Alves, K Evanchik, M Yan, R Huang, Q Lopatin, U Colonno, R Ma, J Knox, SJ Stamm, LM Bonacini, M Jacobson, IM Ayoub, WS Weilert, F Ravendhran, N Ramji, A Kwo, PY Elkhashab, M Hassanein, T Bae, HS Lalezari, JP Fung, SK Sulkowski, MS	2022
	Safety, pharmacokinetics and antiviral activity of ABI-H2158, a hepatitis B virus core inhibitor: A randomized, placebo-controlled phase 1 study Journal:Journal of Viral Hepatitis	Agarwal, K Xu, J Gane, EJ Nguyen, TT Ding, YH Knox, SJ Alves, K Evanchik, M Zomorodi, K Ma, JL Yan, R Huang, Q Colonno, R Stamm, LM Hassanein, TI Kim, DJ Lim, YS Yuen, MF	12-Jan-2023
	The second-generation hepatitis B virus (HBV) core inhibitor (CI) ABI-H2158 is associated with potent antiviral activity in a 14-day monotherapy study in HBeAg-positive patients with chronic hepatitis B (CHB) Proceeding/Conference:Hepatology	Yuen, RMF Agarwal, K Gane, EJ Nguyen, TT Hassanein, T Kim, DJ Alves, K Zayed, H Qiang, DM Ruby, E Evanchik, M Huang, Q Knox, S Colonno, R on behalf of ABI-H2158 Study Team	2019	29

Showing results 5 to 11 of 11 < previous